SCHEMBL4935437

SCHEMBL4935437

Cc1ccc(-n2c(CCC(N)C(=O)NO)nc3cc(C)c(C)cc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 1/20 0.41
▸ NTRK2 Q16620 1/20 0.41
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ PDE10A Q9Y233 8/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MITF O75030 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ESR1 P03372 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ MAPT P10636 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4936237 1.00 NTRK1 (0.41) NTRK1NTRK2MEN1KMT2APDE10A
SCHEMBL4935414 1.00 NTRK1 (0.41) NTRK1NTRK2MEN1KMT2APDE10A
SCHEMBL4934374 0.92 HDAC6 (0.37) NTRK1NTRK2MEN1KMT2APDE10A
SCHEMBL4934387 0.92 HDAC6 (0.37) NTRK1NTRK2MEN1KMT2APDE10A
SCHEMBL4933134 0.91 NTRK1 (0.44) NTRK1NTRK2MEN1KMT2APDE10A
SCHEMBL4932046 0.91 NTRK1 (0.44) NTRK1NTRK2MEN1KMT2APDE10A
SCHEMBL4932064 0.91 NTRK1 (0.44) NTRK1NTRK2MEN1KMT2APDE10A
SCHEMBL4931996 0.90 KDM4E (0.41) MEN1KMT2APDE10AHDAC6KDM4E
SCHEMBL4932009 0.90 KDM4E (0.41) MEN1KMT2APDE10AHDAC6KDM4E
SCHEMBL4935309 0.87 NTRK1 (0.53) NTRK1NTRK2MEN1KMT2APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 — — US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 NTRK1 4781/4885NTRK2 4153/4885MEN1 3049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback